Showing 261-270 of 1560 results for "".
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
https://reachmd.com/programs/neurofrontiers/engineering-autoimmunity-a-new-model-for-studying-ms-progression-and-remyelination/32706/Learn about a novel CAR T-cell model that can offer a more reproducible approach to studying multiple sclerosis.Nanrilkefusp Alfa: A Promising Subcutaneous IL-15Rβγ Superagonist
https://reachmd.com/programs/spotlight-subcutaneous-cancer-immunotherapies/nanrilkefusp-alfa-a-promising-subcutaneous-il-15r-superagonist/32991/Read about the mechanisms, safety, and efficacy of nanrilkefusp alfa, an IL-15 receptor βγ superagonist designed to stimulate NK and CD8+ T cells.Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC
https://reachmd.com/programs/project-oncology/concerning-kinases-therapeutic-considerations-for-ret-rearranged-nsclc/12428/What do we need to know about targeted therapy options for patients with RET rearranged non-small cell lung cancer?Addressing Opioid Misuse and Abuse: A Focus on REMS Programs
https://reachmd.com/programs/lifelong-learning/addressing-opioid-misuse-abuse-rems-programs/7336/There is a national public health crisis concerning the misuse and overuse of opioid medications, and despite multiple large scale efforts to stem the tide, negative trends persist. In order to address risk and safety concerns, reduce serious adverse outcomes, and simultaneously ensure that pain patAttaining the Best Glucose Control Safely
https://reachmd.com/programs/diabetes-discourse/attaining-the-best-glucose-control-safely/6631/Host Dr. Farhad Zangeneh welcomes Dr. George Grunberger on a discussion on how to attain the best glucose control for our patients and how to do it safely. The discussion stems from altering lifestyle changes for our patients, addressing how to set individualized targets for our patients and identifThe Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
https://reachmd.com/programs/book-club/vaccine-race-science-politics-and-human-costs-defeating-disease/9986/Meredith Wadman tells the story of how a major breakthrough in cell biology led to the eradication of rubella and other devastating diseases.The Science of Regenerative Medicine and Exosomes
https://modernaesthetics.com/topics/skincare/the-science-of-regenerative-medicine-and-exosomes/35186/Exosomes hold promise for medical and aesthetic applications, but there is much to learn about sourcing and optimal applicationExploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19
https://reachmd.com/programs/the-drug-report/exploring-the-emergency-use-authorization-for-a-monoclonal-antibody-cocktail-for-covid-19/12025/Here’s what led the FDA to issue an EUA for the coadministration of casirivimab and imdevimab to block COVID-19’s attachment and entry into cells.Individualized Care in Advanced NSCLC: Putting the Patient First
https://reachmd.com/programs/medical-industry-feature/individualized-care-in-advanced-nsclc-putting-the-patient-first/26558/With a range of therapeutic options available, treatments can be tailored to help meet the needs of patients with advanced non-small cell lung cancer.NSCLC Care: Evaluating Durvalumab in the First-Line Setting
https://reachmd.com/programs/project-oncology/nsclc-care-evaluating-durvalumab-in-the-first-line-setting/16499/What is the safety and efficacy of durvalumab as a first-line therapy for patients with metastatic non-small cell lung cancer? Tune in to find out.